NOBIAS THERAPEUTICS Trademark
Trademark Overview
On Thursday, May 13, 2021, a trademark application was filed for NOBIAS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NOBIAS THERAPEUTICS trademark a serial number of 90708830. The federal status of this trademark filing is REGISTERED as of Tuesday, July 19, 2022. This trademark is owned by Nobias Therapeutics, Inc.. The NOBIAS THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations and substances for use in the treatment of pediatric genetic disorders; pharmaceutical preparations and substances to actively fight rare, congenital, and potentially life-threatening pediatric diseases
Pharmaceutical research, drug discovery and drug development services; medical and scientific research in the field of pediatric genetic disorders; research and development of pharmaceutical preparations for the treatment of rare, congenital, and potentially life-threatening pediatric diseases
General Information
Serial Number | 90708830 |
Word Mark | NOBIAS THERAPEUTICS |
Filing Date | Thursday, May 13, 2021 |
Status | 700 - REGISTERED |
Status Date | Tuesday, July 19, 2022 |
Registration Number | 6799067 |
Registration Date | Tuesday, July 19, 2022 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, March 15, 2022 |
Trademark Statements
Goods and Services | Pharmaceutical preparations and substances for use in the treatment of pediatric genetic disorders; pharmaceutical preparations and substances to actively fight rare, congenital, and potentially life-threatening pediatric diseases |
Pseudo Mark | NO BIAS THERAPEUTICS |
Disclaimer with Predetermined Text | "THERAPEUTICS" |
Goods and Services | Pharmaceutical research, drug discovery and drug development services; medical and scientific research in the field of pediatric genetic disorders; research and development of pharmaceutical preparations for the treatment of rare, congenital, and potentially life-threatening pediatric diseases |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 13, 2021 |
Primary Code | 005 |
First Use Anywhere Date | Tuesday, March 15, 2022 |
First Use In Commerce Date | Tuesday, March 15, 2022 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 13, 2021 |
Primary Code | 042 |
First Use Anywhere Date | Thursday, February 10, 2022 |
First Use In Commerce Date | Thursday, February 10, 2022 |
Trademark Owner History
Party Name | Nobias Therapeutics, Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Wayne, PA 19087 |
Party Name | Nobias Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Wayne, PA 19087 |
Party Name | Nobias Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Wayne, PA 19087 |
Trademark Events
Event Date | Event Description |
Tuesday, July 19, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, July 19, 2022 | REGISTERED-PRINCIPAL REGISTER |
Saturday, June 11, 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Friday, June 10, 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Tuesday, June 7, 2022 | STATEMENT OF USE PROCESSING COMPLETE |
Friday, May 20, 2022 | USE AMENDMENT FILED |
Tuesday, June 7, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Friday, May 20, 2022 | TEAS STATEMENT OF USE RECEIVED |
Tuesday, May 10, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, March 15, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, March 15, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, February 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, February 9, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, January 28, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, January 27, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, January 27, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, January 21, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, January 21, 2022 | NON-FINAL ACTION E-MAILED |
Friday, January 21, 2022 | NON-FINAL ACTION WRITTEN |
Friday, January 21, 2022 | ASSIGNED TO EXAMINER |
Friday, August 13, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Monday, May 17, 2021 | NEW APPLICATION ENTERED IN TRAM |